BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 313,800 shares, a decline of 61.7% from the January 15th total of 820,000 shares. Approximately 2.7% of the shares of the stock are short sold. Based on an average daily volume of 3,880,000 shares, the days-to-cover ratio is presently 0.1 days.

BioNexus Gene Lab Stock Up 7.0 %

BioNexus Gene Lab stock traded up $0.02 during trading hours on Thursday, hitting $0.38. The stock had a trading volume of 13,958 shares, compared to its average volume of 7,423,802. BioNexus Gene Lab has a 1-year low of $0.21 and a 1-year high of $1.40. The stock’s fifty day moving average is $0.33 and its two-hundred day moving average is $0.37.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.